Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Linamarase (EC 3.2.1.21) is a plant-derived $\beta$-glucosidase enzyme, notably found in cassava (*Manihot esculenta*), flax, and white clover, that plays a central role in cyanogenesis—the release of hydrogen cyanide (HCN) from cyanogenic glycosides like linamarin. This enzymatic reaction is a natural defense mechanism in plants against herbivory. In a therapeutic context, linamarase is being researched for use in gene-directed enzyme prodrug therapy (GDEPT), where the linamarase gene is delivered to tumor cells (e.g., glioblastoma) to locally convert the non-toxic prodrug linamarin into lethal cyanide, thereby inducing cell death. Beyond its potential as an antineoplastic agent, linamarase is utilized in food science for the detoxification of cassava products and as an analytical tool for quantifying cyanogenic compounds in food samples.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on linamarase.